CLAFICAPAVIR
UNII H8ENW8T6SL

Substance Identification & Data

This profile provides standardized clinical and technical data for Claficapavir, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H8ENW8T6SL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2055732-24-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H8ENW8T6SL

CAS Registry Number

2055732-24-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CLAFICAPAVIR

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H12ClNO4S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

YZLFZFALAZYTCI-ZROIWOOFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C188582

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

1286537

Unique identification number in the NCBI database of chemical substances.

INN ID

11705

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(=C\1/C(=O)N(CCC(O)=O)C(=S)S1)\c2oc(cc2)-c3ccc(Cl)cc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Claficapavir. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.